Riverside Clinical Research
Riverside Clinical Research is a single-site clinical research facility in Edgewater, Florida, operating as Velocity Clinical Research's New Smyrna Beach site since its 2021 acquisition. The site conducts Phase I-IV clinical trials in vaccines, orthopedic, gastroenterology, and neurology for pharmaceutical and biotechnology sponsors.
- Company typePrivate
- Founded2010
- HeadquartersEdgewater, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Riverside Clinical Research does
Riverside Clinical Research is a single-site clinical research facility located in Edgewater (New Smyrna Beach), Florida, operating as Velocity Clinical Research's New Smyrna Beach site since its 2021 acquisition. Founded in 2010, the site conducts Phase I-IV clinical trials across multiple therapeutic areas including vaccines, orthopedic, gastroenterology, and neurology for pharmaceutical and biotechnology sponsors. The facility features a CLIA-certified research laboratory, Electronic Data Capture (EDC) systems, secure temperature-controlled investigational product storage, advanced specimen storage capabilities at -20 and -70 degrees Celsius, and infrastructure for extended-stay pharmacokinetic studies. All trials are conducted in accordance with ICH and FDA guidelines under Good Clinical Practice (GCP) standards.
The site is staffed by three board-certified principal investigators—Margaret Chang, MD (25+ years medical experience, 10 years in clinical trials); Patricia Fredette, MD (20+ years experience, 9 years in clinical trials); and Sandra Buchanan, MD (2 years in clinical research)—alongside GCP- and HIPAA-trained research staff led by Site Director Anna Kipp. The business operates as a B2B professional services enterprise, generating revenue through individually negotiated clinical trial contracts with pharmaceutical and biotechnology sponsors, with pricing terms customized to trial complexity, duration, and patient enrollment requirements. Patient recruitment is supported through the VelocityClinicalTrials.com platform and social media channels including Facebook, LinkedIn, X, and Instagram.
The site is strategically located along a major highway on Florida's east coast, 3 miles from the local hospital, with private examination rooms, patient reception areas, a nursing station, secure monitoring rooms, regulatory document processing, and patient amenities including a theatre room. As part of Velocity Clinical Research's integrated research site network spanning the US, Europe, and Latin America, the site benefits from centralized capabilities including therapeutic CARE Councils, the VISION technology platform, and unified enterprise business development with pharma and biotech sponsors.
Riverside Clinical Research firmographics
Firmographics- Name
- Riverside Clinical Research
- Legal name
- Velocity Clinical Research
- Website
- https://riversideclinicalresearch.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Riverside Clinical Research is a single-site clinical research facility in Edgewater, Florida, operating as Velocity Clinical Research's New Smyrna Beach site since its 2021 acquisition. The site conducts Phase I-IV clinical trials in vaccines, orthopedic, gastroenterology, and neurology for pharmaceutical and biotechnology sponsors.
- Ownership category
- akta.pro rank
Riverside Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Riverside Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Edgewater
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Riverside Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Services: Contract research organization (CRO) services providing clinical trial conduct for pharmaceutical and biotechnology companies. Revenue generated through clinical trial contracts for drug, medical device, and diagnostic research.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Riverside Clinical Research product offering
Product offeringCore offering
Riverside Clinical Research operates a single-site clinical research facility in Edgewater, Florida, conducting Phase I-IV clinical trials for pharmaceutical and biotechnology sponsors across therapeutic areas including vaccines, orthopedic, gastroenterology, and neurology. Founded in 2010 and acquired by Velocity Clinical Research in 2021, the site delivers patient recruitment, study execution, electronic data capture, and on-site CLIA-certified laboratory services in compliance with FDA, ICH, and GCP standards.
Product overview
Riverside Clinical Research operates as a single-site clinical research facility offering integrated clinical trial services. Originally founded in 2010 and acquired by Velocity Clinical Research in 2021, the site provides end-to-end clinical research capabilities including patient recruitment, study execution, and data management across multiple therapeutic areas including vaccines, orthopedic, gastroenterology, and neurology. The facility features CLIA-certified laboratory capabilities, electronic data capture (EDC) systems, and a team of board-certified physician investigators trained in GCP and HIPAA compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Site Operations
Quantifiable outcome
- Efficient and quality-driven clinical trial conduct
Companies that use Riverside Clinical Research
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Riverside Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Riverside Clinical Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Velocity Clinical Research (Parent Company)coreRiverside Clinical Research was founded in 2010 and acquired by Velocity Clinical Research in 2021. The site now operates as Velocity Clinical Research, New Smyrna Beach location, part of Velocity's integrated research site network.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Riverside Clinical Research competitors and assessment
Company assessmentDirect peers
- Meridian Clinical Research: Privately held, multi-site SMO conducting Phase I-IV trials across vaccines, cardiometabolic and other therapeutic areas — closely comparable in scale, therapeutic mix, and integrated site model.
- DM Clinical Research: Multi-site SMO running Phase I-IV trials across therapeutic areas including vaccines, GI and neurology with a similar physician-investigator-led operating model.
- Accel Research Sites: Multi-therapeutic, multi-site clinical research site network operating across the Southeastern US with a comparable mix of vaccine, GI, neurology and general medicine trials.
- Clinical Trials of Texas: Multi-therapeutic SMO with multiple investigator sites, comparable to Riverside in scale and trial mix, particularly in vaccines and chronic disease indications.
- Centricity Research: Multi-site integrated research site organization (formerly JBR Clinical Research / Quality of Life Medical) operating clinical trial sites with similar Phase I-IV service offerings and sponsor relationships.
Broad incumbents
- IQVIA: Largest global CRO/SMO operator; while not a direct single-site competitor, IQVIA's site network and prime-site programs compete for the same Phase I-IV enterprise contracts Velocity pursues.
- Velocity Clinical Research: Direct parent company operating an integrated multi-site SMO network across the US and Europe; Riverside/NSB is one of its constituent sites, making Velocity the closest structural and operational comparable.
- Medpace: Mid-to-large CRO with embedded site relationships and full-service clinical development capabilities, competing for the same biotech/pharma trial placements that flow through integrated SMO networks.
- Fortrea: Global CRO carved out of LabCorp Drug Development that runs clinical operations including site services; competes with the Velocity network for enterprise pharma/biotech study allocation.
Emerging players
- Javara: Integrated clinical research organization partnering with healthcare practices to embed trial operations, with overlapping therapeutic breadth and pharma-sponsor GTM.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights6 records
Customer concentration
Riverside Clinical Research social profiles
Digital presenceRiverside Clinical Research compliance and trust
Trust signalCompliance2 records
Riverside Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Riverside Clinical Research leadership team
Management profileNumber of profiles
Profiles4 records
Riverside Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Riverside Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Riverside Clinical Research
What does Riverside Clinical Research do?
Riverside Clinical Research operates a single-site clinical research facility in Edgewater, Florida, conducting Phase I-IV clinical trials for pharmaceutical and biotechnology sponsors across therapeutic areas including vaccines, orthopedic, gastroenterology, and neurology. Founded in 2010 and acquired by Velocity Clinical Research in 2021, the site delivers patient recruitment, study execution, electronic data capture, and on-site CLIA-certified laboratory services in compliance with FDA, ICH, and GCP standards.
Is Riverside Clinical Research a public or private company?
Riverside Clinical Research is a private company. It is classified as corporate owned and is currently operating.
When was Riverside Clinical Research founded?
Riverside Clinical Research was founded in 2010. It employs 11 to 50 people.
Where is Riverside Clinical Research based?
Riverside Clinical Research is headquartered in Edgewater, United States, in the North America region.
How does Riverside Clinical Research make money?
One revenue line is on record: clinical Trial Services.
Who are Riverside Clinical Research's main competitors?
Direct peers on record are Meridian Clinical Research, DM Clinical Research, Accel Research Sites, Clinical Trials of Texas and Centricity Research. Broad incumbents are IQVIA, Velocity Clinical Research, Medpace and Fortrea. Javara is listed as an emerging player.
Does Riverside Clinical Research have an API?
No public API is recorded for Riverside Clinical Research.
What industry is Riverside Clinical Research in?
Riverside Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAL, Site Data Management Support (EDC/Source/SDV Readiness). Its NAICS code is 621511 and its SIC code is 8071.